Related Experiment Video
Updated: Oct 1, 2026

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
An integrated framework for clinical surveillance in multiple sclerosis: An evidence-informed narrative review
Ana Herrero Valverde1, Carlos Capela2, Manuel Comabella3
1Neurology Unit, Hospital CUF Descobertas, R. Mário Botas S/N, Parque das Nações, 1998-018 Lisboa, Portugal; NOVA IMS - NOVA Information Management School, Universidade NOVA de Lisboa, Campus de Campolide, 1070-312 Lisboa, Portugal.
Abstract:
An Integrated Framework for Clinical Surveillance in Multiple Sclerosis: an evidenceinformed narrative review Background: Multiple sclerosis (MS) requires structured lifelong surveillance across clinical, imaging, safety and patient-centred domains. We aimed to integrate relevant recommendations and evidence into a practical framework for longitudinal care.
Methods:
We conducted an evidence-informed narrative review of PubMed/MEDLINE, Embase and the Cochrane Library from inception to December 2025, supplemented by society and institutional guidance and reference-list searching. Evidence was synthesised across clinical and cognitive assessment, neuroimaging, laboratory safety monitoring, emerging biomarkers, treatment escalation and de-escalation, vaccination, reproductive health, and a tiered minimal core monitoring set. No formal risk-of-bias assessment or evidence grading was performed.
Results:
The proposed framework integrates clinical and cognitive measures, conventional MRI and drug-specific safety monitoring. NEDA-3 is adopted as the operational treat-to-target framework; NEDA-4 and biomarker-enhanced composites are discussed as emerging extensions. Serum neurofilament light chain and glial fibrillary acidic protein provide complementary prognostic information but do not independently identify progression independent of relapse activity or mandate treatment escalation. Confirmed inflammatory activity is distinguished from disability accumulation and adjunctive biomarker or quantitative imaging signals. Vaccination, reproductive health and symptomatic management are incorporated alongside authorproposed essential, recommended and advanced monitoring tiers.
Conclusion:
This framework is intended to support coordinated, risk-adapted MS surveillance. Its operational recommendations and monitoring tiers require prospective validation, and implementation should reflect patient characteristics, treatment-specific requirements and local resources.
Related Concept Videos
Multiple Sclerosis l: Introduction
Principles of Disease Surveillance
Nursing Clinical Information System
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include:
Clinical Trials: Overview
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic illness...
Clinical Trials
There are four phases in a clinical trial. A phase one...
